Long-Term Outcomes of Immunosuppressive Therapy for Aplastic Anemia: A Single-Center Experience

Background. Bone marrow transplantation-ineligible aplastic anemia (AA) is most effectively treated with combined immunosuppressive therapy (IST). It yields remissions in most patients. However, it has such disadvantages as frequent relapses, incomplete hematologic recovery, and clonal evolution ris...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Elena Romanovna Shilova, N. A. Romanenko, D. A. Chebykina, T. V. Glazanova, M. N. Zenina, I. E. Pavlova, S. S. Bessmeltsev
פורמט:	Artigo
שפה:	Russo
יצא לאור:	Practical Medicine Publishing House 2023-06-01
סדרה:	Клиническая онкогематология
נושאים:	aplastic anemia immunosuppressive therapy remission complications clonal evolution pnh clone pregnancy
גישה מקוונת:	https://bloodjournal.ru/index.php/coh/article/view/40
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!